0

Piloting Structure-Based Drug Design via Modality-Specific Optimal Schedule

A novel VLB-Optimal Scheduling strategy optimizes molecular geometry and interaction modeling in deep generative models, significantly improving PoseBusters passing rates in SBDD.

Year
2025
Venue
arXiv 2025
Authors
8
Hosting
Abstract onlyARXIV-DEFAULT

Cite

Notes

Only stored in your browser.

Attribution

Abstract & full text
arxiv.org/abs/2505.07286v2ARXIV-DEFAULT
TL;DR
Semantic Scholar
Attribution policy →

Abstract

Structure-Based Drug Design (SBDD) is crucial for identifying bioactive molecules. Recent deep generative models are faced with challenges in geometric structure modeling. A major bottleneck lies in the twisted probability path of multi-modalities -- continuous 3D positions and discrete 2D topologies -- which jointly determine molecular geometries. By establishing the fact that noise schedules decide the Variational Lower Bound (VLB) for the twisted probability path, we propose VLB-Optimal Scheduling (VOS) strategy in this under-explored area, which optimizes VLB as a path integral for SBDD. Our model effectively enhances molecular geometries and interaction modeling, achieving state-of-the-art PoseBusters passing rate of 95.9% on CrossDock, more than 10% improvement upon strong baselines, while maintaining high affinities and robust intramolecular validity evaluated on held-out test set. Code is available at https://github.com/AlgoMole/MolCRAFT.

Authors

8